Posted: June 2, 2017

Targeting Inappropriate Ordering of the Prostate–Specific Antigen (PSA) Test in Primary Care at the Veterans Affairs Loma Linda Healthcare System (VALLHS)

Description

The guidelines for prostate cancer (PCa) screening using prostate specific antigen (PSA) are controversial. This is largely due to the narrow margin of the ratio of benefit (lives saved) to harm (false-positive results and detection of indolent PCa leading to unnecessary biopsies and treatment, significant adverse effects, and decreased quality of life). However, there are two recommendations that are consistent among all current expert guidelines. First, screening is not recommended in asymptomatic men younger than 45 and older than 70 years old; second, PSA screening should not be ordered without a discussion with the patient of the risks and benefits of screening. The goal of this project was to facilitate primary care provider (PCP) adherence to the aforementioned guidelines.

Keywords

Prostate Cancer Screening, PSA Screening, Unnecessary Screening

Authors

Alex Fernando Ramos, MD, MPH, Veterans Affairs Loma Linda Health Care System

John Byrne, DO, VA Loma Linda Healthcare System

Ralph Clark, MD, MPH, VA Loma Linda Healthcare System

Susan Hall, MD, MPH, PhD, Veterans Affairs Loma Linda Health Care System

Luther M. Borgardt, RN, Veterans Affairs Loma Linda Health Care System

Janelle T. Anderson, MD, Veterans Affairs Loma Linda Health Care System

Karen R. Studer, MD, MPH, Veterans Affairs Loma Linda Health Care System


Comments